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Editorial 
The first step in the management of a condition is spotting it, but in the case of sepsis this can prove 
difficult.  Earlier this year the International Consensus definitions of sepsis changed, with emphasis 
moving away from the inflammatory response towards organ dysfunction resulting from infection, and 
the term severe sepsis being made redundant
1
. The criteria for systemic inflammatory response are 
present in as many as four out of five critically ill patients and lacks diagnostic accuracy
2
. The new 
definition now focuses on the presence of organ dysfunction and whether it may have resulted from 
infection.  There has already been significant debate about the validity of this new definition, largely 
evidenced by data from in-hospital care in parts of North America
3,4
.  However, the major emphasis of 
the new definition is on a simplified system for early suspicion of organ dysfunction resulting from 
suspected infection, rather than a precise pathological definition for sepsis.  Despite high predictive 
value (AUROC = 0.81; 95% CI, 0.80-0.82)
5
, critics of the new definition have highlighted that the use 
of qSOFA score has not been fully validated in the various clinical settings where sepsis may present
4 
 
It has also been pointed out that low income countries were not involved in the new consensus 
process where early diagnosis and awareness are key to sepsis management
4
. The change in 
definitions could mean that findings from previous large international research studies may need to be 
re-interpreted.  Considering that such debate remains about the definitions of sepsis and their 
purpose, how can clinicians, or indeed the public, be expected to spot it with confidence? 
Recognising sepsis as a clinician 
The Surviving Sepsis Campaign has helped to put sepsis at the forefront of clinician’s minds, but 
mortality and morbidity from sepsis remains excessively high. Hospital mortality from sepsis is quoted 
as 25-30% and higher at 40-50% if patients have septic shock
6,7
and patients who survive an episode 
of sepsis have a significant excess risk of mortality for a prolonged period of time
8,9
.  High quality care 
must begin with accurate diagnosis, yet there are still accounts of cases of unrecognised sepsis, as 
highlighted by the recent reports by the Parliamentary and Health Service Ombudsman and the 
National Confidential Enquiry into Patient Outcomes and Death (NCEPOD)
 10,11
.  These reports 
demonstrate that there are shortcomings in both the public’s and healthcare professionals’ knowledge 
of sepsis, adding to the likelihood of cases of sepsis presenting late or its diagnosis being missed 
altogether
12
 .  Furthermore, competing demands on time and resources, busy staff and an 
overburdened healthcare system can all contribute to late recognition and delayed management of 
sepsis. 
What may still prove difficult is catching those patients in the very early stages of sepsis. Despite on-
going research, a diagnostic clinical or biochemical biomarker for sepsis continues to elude 
us
13
.Ideally, a test of some sort is needed to say definitively “this patient has sepsis” or to exclude it, 
but due to the heterogeneity of sepsis as a syndrome, there are no tests with the necessary sensitivity 
and specificity in existence
14
.  The lack of precise diagnostic criteria or definition also impacts on 
clinical research development, in particular making the identification of cases, evaluation of the 
efficacy of treatment and assessment of patient outcomes more problematic. Without the appropriate 
and timely diagnosis of sepsis, clinical trials investigating novel biomarkers remain methodologically 
challenging. 
How can we improve our ability to spot sepsis? New draft guidelines from the National Institute for 
Health and Care Excellence (NICE) include recommendations on when to suspect sepsis, highlighting 
the need to be vigilant when symptoms are vague
15
. Whilst this may help to raise the suspicion of 
sepsis earlier, it still relies on clinicians’ ability to spot the diagnosis. One approach to overcome this 
issue involves the utilisation of electronic recording of observations, where an alert is activated when 
the patient’s observations suggest sepsis
16
. This may at least flag these patients to healthcare 
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professionals, so that appropriate investigations and further management can be implemented in a 
timely fashion. This does away with some of the human error involved in monitoring patients, but 
correct management will still require engagement and appropriate actions from clinicians on the 
findings.  
“Can I catch it?” – Public understanding of sepsis 
In a recent study of survivors of severe sepsis there were a number of patients that had not even 
known that they had been treated for sepsis until they were approached by the study investigators
17
.  
Considering the lack of understanding of those with first-hand experience of the condition, it is 
unsurprising to think that the general public is disadvantaged when it comes to awareness of sepsis. 
Questions from members of the public at a recent patient and public involvement meeting that one 
author attended included “can I catch it?”, demonstrating the conceptual difficulties and challenges for 
healthcare professionals in communicating messages about sepsis. 
There has recently been media attention to sepsis due to some high profile cases, such as William 
Mead and Charlie Jermyn, both of whom were children. This helps to raise the public profile of sepsis, 
but will not improve the public’s ability to recognise the syndrome.  It also demonstrates the additional 
difficulty of diagnosing sepsis in children; NICE guidelines highlight the very young as an at risk 
population for the development of sepsis, with the extra complexity of different signs and symptoms of 
sepsis compared to adults
15
. Yet the new definitions of sepsis focus on adult patients only; the 
diagnostic criteria has not been validated in children, and would be inappropriate considering the 
differing physiological parameters found in children of different ages
1
. However, the new NICE 
guidelines on sepsis do focus on clinical signs and symptoms in children that are suspicious of sepsis, 
and includes guidance on the management of sepsis in children
15
. An international definition for 
sepsis in children is needed to ensure prompt recognition and management of sepsis in children 
worldwide.  
Public campaigns to improve recognition of other diseases such as myocardial infarction and stroke 
have helped to improve mortality in these areas through earlier treatment due to prompt recognition
18
. 
NHS England has stated that it will support the development of a public awareness campaign on 
sepsis amongst vulnerable groups and the UK Sepsis Trust has developed a list of warning signs to 
look out for with the acronym S.E.P.S.I.S., in the same vein as the F.A.S.T. signs for stroke
11
. 
However, the early symptoms of sepsis are vague, often resembling less severe illnesses such as a 
common cold, making it difficult for lay people and healthcare professionals alike to discriminate a 
bout of ‘man-flu’ from life-threatening sepsis. More research is required to explore the public 
understanding of sepsis and it’s definition to help guide a systematic public awareness programme. 
The future for spotting sepsis 
Only time can tell what impact the new definition will have on the recognition of sepsis, although the 
current revision has been focused on delivering improved awareness of the syndrome, providing 
potentially improved functionality for healthcare professionals. Research aimed at investigating the 
diagnostic utility of the new definitions in other jurisdictions and care settings outside of hospital are 
urgently required.  
Increasing clinician recognition of sepsis requires further training and education, as well as research 
into potential biomarkers of relevance to the recognition and treatment of sepsis. In particular, 
emerging rapid biomarkers of infection could contribute significantly to diagnosis and theranosis for 
sepsis, but according to NICE require better evidence of clinical and cost effectiveness before routine 
service adoption
15, 19,20
. 
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Public understanding of sepsis can only realistically be improved through national media campaigns, 
but it’s still unclear what the message should be – if a healthcare professional can’t spot it, how can a 
lay person be expected to recognise sepsis? Further research should look for potential gaps in public 
understanding, allowing any future media campaigns to be tailored to those knowledge gaps. 
Most of the data on sepsis is from the Critical Care setting
21
, yet it is on the wards and pre-hospital 
where sepsis develops but is not recognised. Further data is needed on sepsis in the non-Critical 
Care setting so that the full extent of the prevalence of sepsis can be appreciated. Until we can 
definitively recognise and diagnose sepsis both pre-hospital and in the hospital, we will continue to 
miss cases, leading to increased morbidity and mortality from the disease. In the meantime, we must 
focus our attention on continuing to raise awareness of sepsis, putting sepsis at the forefront of our 
minds and in our lists of differentials, so that the highest quality care can be delivered, resulting in the 
best patient outcomes.   
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